p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14ARF-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells

作者: Shigeki Takemoto , Raffaella Trovato , Anna Cereseto , Christophe Nicot , Tatiana Kislyakova

DOI: 10.1182/BLOOD.V95.12.3939

关键词:

摘要: Human T-cell lymphotropic virus type I (HTLV-I) transforms T cells in vitro, and the viral transactivator Tax functionally impairs tumor suppressor p53 protein, which is also stabilized HTLV-I–infected cells. Thus, functional impairment of essential to maintain viral-induced proliferation CD4+ mature However, leukemic patients with adult leukemia/lymphoma (ATLL), does not appear be expressed, mutations have been found only a fraction patients. We sought investigate whether function impaired, ex vivo samples from ATLL, absence genetic mutations. Here we demonstrate that protein ATLL (10 10 studied) at least 2 stabilization was associated mutation. Furthermore, assessment after ionizing radiation indicated an abnormal induction p53-responsive genes GADD45 p21WAF1 7 In patients, regulation cell-cycle progression appeared impaired as well. Because part regulatory loop involves MDM2 p14ARF, status latter proteins assessed cultured or fresh The p97 detected by Western blot analysis established lines cell lysates. could easily treatment specific proteasome inhibitor lactacystin, suggesting normal p53–MDM2 regulating loop. Similarly, p14ARF did aberrantly expressed nor any studied. HTLV-I infection occurs mutation alteration physiologic degradation pathway p53.

参考文章(38)
Alidad Mireskandari, Robert L. Reid, John N. Brady, Paul F. Lindholm, Jürgen Dittmer, Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I Oncogene. ,vol. 8, pp. 3029- 3036 ,(1993)
Y. Haupt, Y. Barak, M. Oren, Cell type-specific inhibition of p53-mediated apoptosis by mdm2. The EMBO Journal. ,vol. 15, pp. 1596- 1606 ,(1996) , 10.1002/J.1460-2075.1996.TB00504.X
Jiandong Chen, Jiayuh Lin, Arnold J. Levine, Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene Molecular Medicine. ,vol. 1, pp. 142- 152 ,(1995) , 10.1007/BF03401562
K G Low, L F Dorner, D B Fernando, J Grossman, K T Jeang, M J Comb, Human T-cell leukemia virus type 1 Tax releases cell cycle arrest induced by p16INK4a. Journal of Virology. ,vol. 71, pp. 1956- 1962 ,(1997) , 10.1128/JVI.71.3.1956-1962.1997
David Sidransky, Geoffrey I. Shapiro, Christian D. Edwards, Li Mao, Barrett J. Rollins, Gauri Bedi, Adrian Merlo, A Novel p16INK4A Transcript Cancer Research. ,vol. 55, pp. 2995- 2997 ,(1995)
Sean V. Tavtigian, Harold Katcher, Priya Dayananth, Steven Stone, Ping Jiang, David Parry, Alexander Kamb, Gordon Peters, Complex Structure and Regulation of the P16 (MTS1) Locus Cancer Research. ,vol. 55, pp. 2988- 2994 ,(1995)
Y Hatta, Y Yamada, M Tomonaga, HP Koeffler, Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL) Leukemia. ,vol. 11, pp. 984- 989 ,(1997) , 10.1038/SJ.LEU.2400686
Edward L Murphy, Barrie Hanchard, J Peter Figueroa, William N Gibbs, Wycliffe S Lofters, M Campbell, JJ Goedert, William A Blattner, None, Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. International Journal of Cancer. ,vol. 43, pp. 250- 253 ,(1989) , 10.1002/IJC.2910430214
R. Day, B. Johnson, M. Skolnick, A Kamb, N. Gruis, J Weaver-Feldhaus, Q Liu, K Harshman, S. Tavtigian, E Stockert, A cell cycle regulator potentially involved in genesis of many tumor types Science. ,vol. 264, pp. 436- 440 ,(1994) , 10.1126/SCIENCE.8153634